According to TechSci Research report, “Global Topical Drug Delivery Market By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products) By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery) By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) By Distribution Channel (Online vs. Offline) By Region, Competition Forecast & Opportunities, 2026”, the global topical drug delivery market is anticipated to show a robust growth with an impressive CAGR in the forecast period, 2022-2026. The market growth can be attributed to the increasing prevalence of burn injuries and skin diseases. Also, growing prevalence of eye infection is driving the market growth in the upcoming five years. Skin and soft tissue infections are highly prevailing diseases that require the topical drug delivery thus, it drives the global topical drug delivery market growth in the next five years.
Global burden of disease project, mentioned in one of its report that skin diseases like psoriasis, eczema, skin cancer, and vitiligo are major cause of non-fatal disease worldwide and infects a huge number of global populations. Top players like Nestlé Skin Health, Mylan, etc. have adopted various strategies to enhance their position in the competitional landscape. For example, Nestlé Skin Health opened a new office in Malaysia to strengthen their position in the Asia Pacific region. Mylan launched its diclofenac sodium gel, that treats osteoarthritis pain, swelling and stiffening in the joints with excellent performance. Crescita Therapeutics and Cantabria labs came to a partnership that out-licensed an agreement for the sales and distribution of topical Pliaglis formulation in Italy, Portugal, France, and Spain.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “ Global Topical Drug Delivery Market”
https://www.techsciresearch.com/report/topical-drug-delivery-market/7362.html
The global topical drug delivery market is segmented by product, route of administration, end-user, distribution channel, regional distribution, and competitional landscape. Based on route of administration, the market is further sub-segmented into dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery. Dermal drug delivery is anticipated to dominate the market in the forecast years, on the account of convenience and greater patient compliance.
Topical administration of the drugs is favored route for local administrations of therapeutic agents due to its convenience and affordability. The therapeutic system requires an optimal concentration of certain drugs at the target site for appropriate duration. This route of administration of the drugs fulfills the requirement of controlled and prolonged drug delivery and is quite competitive for oral administration mode of drug delivery. Furthermore, the rising prevalence of skin disorders will support the global topical drug delivery market growth in the forecast period, 2022-2026.
Some of the major competitors in the global market are Johnson & Johnson SA, Nestlé SA, GlaxoSmithKline Plc, Novartis AG, Merck & Co. Inc., Crescita Therapeutics Inc., Cipla Ltd., Taro Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Glenmark Pharmaceuticals Ltd., Bayer AG, Encore Dermatology, Inc., MedPharm Group Ltd., Skinvisible Pharmaceuticals, Inc., Galderma S.A., among others. Other strategies include extensive research and development under the guidance of FDA as well as the partnerships among the top players to bring the best quality assured products in the market.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=7362
Customers can also request for 10% free customization on this report.
“Asia Pacific is the anticipated largest market share in the forecast period, on account of increasing prevalence of skin diseases. The region also has a high scale usage of contraceptives which is a major factor for the market growth in the region. Pharmaceutical companies including the top players are actively involved in the research and development of the more effective drugs and smart transdermal drug delivery systems. Home care segment is prevailing on account of increasing incidences of prolonged patient care. In-patient care for a prolonged period is difficult and halts normal lifestyle of the patients, thus home care for such patients is a better alternative and thus it is a promising sector for the future investments. New drugs and their delivery system advancements is the potential strategic recommendation for a new player entering the market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Topical Drug Delivery Market By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products) By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery) By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) By Distribution Channel (Online vs. Offline) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global topical drug delivery and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global topical drug delivery.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website : https://www.techsciresearch.com